Immuron (IMRN) Accumulated Expenses (2017 - 2025)
Immuron (IMRN) posted quarterly Accumulated Expenses of $348064.9 for Q2 2025, down 65.9% year-on-year from $1.0 million in Q2 2024, and down 65.9% on a QoQ basis from $1.0 million in Q2 2024.
Immuron (IMRN) Accumulated Expenses (2017 - 2025) Analysis & Trends
Immuron (IMRN) has reported Accumulated Expenses for 9 consecutive years, with $348064.9 the latest figure, recorded in Q2 2025.
- Quarterly Accumulated Expenses fell 65.9% year-over-year to $348064.9 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $348064.9 (down 65.9% YoY) and the FY2025 annual result came in at $348064.9, down 65.9% from the prior year.
- Accumulated Expenses fell to $348064.9 in Q2 2025 per IMRN's latest filing, from $1.0 million in the prior quarter.
- Over the last five years, Accumulated Expenses for IMRN reached as high as $1.0 million in Q2 2024 and fell as low as $67748.8 in Q2 2022.
- A 5-year average of $281787.9 and a median of $150442.8 in 2021 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Accumulated Expenses soared 451.56% — and 2025, when it sank 65.9%.
- Year by year, Accumulated Expenses stood at $150442.8 in 2021, then tumbled by 54.97% to $67748.8 in 2022, then surged by 451.56% to $373673.0 in 2023, then soared by 173.18% to $1.0 million in 2024, then sank by 65.9% to $348064.9 in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $348064.9, $1.0 million, and $373673.0 for Q2 2025, Q2 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 348,064.95 |
| Jun 30, 2024 | 1.02 Mn |
| Dec 31, 2023 | 373,673.00 |
| Jun 30, 2023 | 289,408.00 |
| Dec 31, 2022 | 67,748.84 |
| Aug 31, 2022 | 67,748.84 |
| Jun 30, 2022 | 67,748.84 |
| Dec 31, 2021 | 150,442.80 |
| Jun 30, 2021 | 150,442.80 |
| Jun 30, 2020 | 148,825.55 |
| Jun 30, 2019 | 251,292.39 |
| Jun 30, 2018 | 307,405.48 |
| Jun 30, 2017 | 401,833.36 |